(2024)
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes.
ARCHIVES OF PHARMACAL RESEARCH.
47,
1
(2023)
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone.
ARCHIVES OF PHARMACAL RESEARCH.
46,
8
(2023)
Adinazolam, a Benzodiazepine-Type New Psychoactive Substance, Has Abuse Potential and Induces Withdrawal Symptoms in Rodents.
ACS CHEMICAL NEUROSCIENCE.
14,
18
(2023)
Designer Drug, 25D-NBOMe, Has Reinforcing and Rewarding Effects through Change of a Dopaminergic Neurochemical System.
ACS CHEMICAL NEUROSCIENCE.
14,
15
(2023)
Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects.
ARCHIVES OF PHARMACAL RESEARCH.
46,
5
(2023)
Potential Functional Role of Phenethylamine Derivatives in Inhibiting Dopamine Reuptake: Structure-Activity Relationship.
BIOMOLECULES & THERAPEUTICS.
31,
1
(2022)
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects.
ARCHIVES OF PHARMACAL RESEARCH.
46,
2
(2022)
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone.
ARCHIVES OF PHARMACAL RESEARCH.
46,
1
(2022)
Mepirapim, a novel synthetic cannabinoid, induces Parkinson's disease-related behaviors by causing maladaptation of the dopamine system in the brain.
ARCHIVES OF TOXICOLOGY.
97,
2
(2022)
Structure-Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor.
BIOMOLECULES & THERAPEUTICS.
35,
1
(2022)
Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes.
Archives of Pharmacal Research.
45,
8
(2022)
Repeated Morphine Administration Increases TRPV1 mRNA Expression and Autoradiographic Binding at Supraspinal Sites in the Pain Pathway.
BIOMOLECULES & THERAPEUTICS.
30,
4
(2022)
Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents.
PHARMACEUTICALS.
15,
6
(2022)
Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes.
ARCHIVES OF PHARMACAL RESEARCH.
45,
6
(2022)
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism.
ARCHIVES OF PHARMACAL RESEARCH.
45,
5
(2022)
Korean Red Ginseng inhibits methamphetamine addictive behaviors by regulating dopaminergic and NMDAergic system in rodents.
JOURNAL OF GINSENG RESEARCH.
46,
1
(2021)
Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes.
ARCHIVES OF PHARMACAL RESEARCH.
44,
12
(2021)
Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients.
ARCHIVES OF PHARMACAL RESEARCH.
44,
12
(2021)
Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin to related CYP2D6*10 allele.
ARCHIVES OF PHARMACAL RESEARCH.
44,
11
(2021)
Methoxphenidine (MXP) induced abnormalities: Addictive and schizophrenia-related behaviours based on an imbalance of neurochemicals in the brain.
BRITISH JOURNAL OF PHARMACOLOGY.
178,
19
Publications
(2020)
인체해부생리학.
라이프사이언스.
Co-author
(2019)
이우주의 약리학강의.
신일서적.
Co-author
(2018)
약물학.
범문에듀케이션.
Co-author
(2016)
약물학 정리와 시험.
신일북스.
Lead author
(2015)
약물작용기본이론.
군자출판사.
Co-author
(2015)
약물학.
범문에듀케이션.
Co-author
(2014)
신경정신약리학.
신일서적.
Lead author
(2013)
임상약리와 약물치료.
신일북스.
Co-author
(2012)
약리학 정리와 시험.
신일북스.
Lead author
(2012)
약물학.
신일북스.
Co-author
(2009)
약물학.
신일북스.
Co-author
(2007)
신경과학.
월드사이언스.
Co-author
(2007)
스포츠기능성보조제.
신일북스.
Co-author
(2007)
약물학.
신일북스.
Co-author
(2006)
약학입문.
신일상사.
Co-author
(2005)
약물학.
신일상사.
Co-author
(2005)
약학입문.
신일상사.
Co-author
(2004)
약물학연습.
신일상사.
Co-author
(2004)
스포츠와 약물.
도서출판 홍경.
Co-author
(2004)
약물학독성학 실험.
신일상사.
Co-author
Patent/Intellectual Property
정량적 구조-활성 관계 모델과 그래픽 사용자 인터페이스를 이용한 화합물의 중독성 예측 방법 및 이를 수행하는 장치.
10-2020-0029045.
20220622.
KOREA, REPUBLIC OF
오수유 추출물 또는 에보디아민을 유효성분으로 포함하는 카페인 중독에 의한 질환의 예방 또는 치료용 조성물.
201780075654.2.
20220517.
CHINA
오수유 추출물 또는 에보디아민을 유효성분으로 포함하는 카페인 중독에 의한 질환의 예방 또는 치료용 조성물.
2019-550534.
20210108.
JAPAN
신규한 HDAC6 억제제를 이용한 치매 또는 인지장애 예방 또는 치료용 약학적 조성물.
10-2018-0045283.
20200212.
KOREA, REPUBLIC OF
채송화(Portulaca grandiflora Hook.) 추출물 또는 이의 분획물을 유효성분으로 포함하는 신경염증 또는 퇴행성 뇌신경 질환의 예방 또는 치료용 약학적 조성물(Pharmaceutical composition for prevention or treatment neuro-inflammation or neurodegenerative diseases comprising Portulaca grandiflora Hook. extracts or fractions thereof).
10-1815-5730000.
20190910.
UNITED STATES
싸리나무 추출물을 유효성분으로 하는 학습 및 기억력 증진 또는 치매 예방 및 치료용 약학적 조성물.
10-2018-0045802.
20190903.
KOREA, REPUBLIC OF
오수유 추출물 또는 에보디아민을 유효성분으로 포함하는 카페인 중독에 의한 질환의 예방 또는 치료용 조성물(Composition for the preventing or treating of caffeinism comprising Evodia officinalis or evodiamine).
10-1923-7210000.
20181123.
JAPAN
오수유 추출물 또는 에보디아민을 유효성분으로 포함하는 카페인 중독에 의한 질환의 예방 또는 치료용 조성물(Composition for the preventing or treating of caffeinism comprising Evodia officinalis or evodiamine).
10-1923-7210000.
20181123.
KOREA, REPUBLIC OF
채송화(Portulaca grandiflora Hook.) 추출물 또는 이의 분획물을 유효성분으로 포함하는 신경염증 또는 퇴행성 뇌신경 질환의 예방 또는 치료용 약학적 조성물(Pharmaceutical composition for prevention or treatment neuro-inflammation or neurodegenerative diseases comprising Portulaca grandiflora Hook. extracts or fractions thereof).
10-1815573-0000.
20180803.
CHINA
채송화(Portulaca grandiflora Hook.) 추출물 또는 이의 분획물을 유효성분으로 포함하는 신경염증 또는 퇴행성 뇌신경 질환의 예방 또는 치료용 약학적 조성물(Pharmaceutical composition for prevention or treatment neuro-inflammation or neurodegenerative diseases comprising Portulaca grandiflora Hook. extracts or fractions thereof).
10-1815573-0000.
20180803.
JAPAN
채송화(Portulaca grandiflora Hook.) 추출물 또는 이의 분획물을 유효성분으로 포함하는 신경염증 또는 퇴행성 뇌신경 질환의 예방 또는 치료용 약학적 조성물.
10-2014-0112668.
20171226.
KOREA, REPUBLIC OF
채송화(Portulaca grandiflora Hook.) 추출물 또는 이의 분획물을 유효성분으로 포함하는 신경염증 또는 퇴행성 뇌신경 질환의 예방 또는 치료용 약학적 조성물.
10-2014-0112668.
20171226.
KOREA, REPUBLIC OF
모새나무 추출물을 포함하는 학습장애, 기억력 장애 또는 치매의 예방 또는 치료용 조성물.
10-2014-0112667.
20170705.
KOREA, REPUBLIC OF
모새나무 추출물을 포함하는 학습장애, 기억력 장애 또는 치매의 예방 또는 치료용 조성물.
10-2014-0112667.
20170705.
KOREA, REPUBLIC OF
소량의 항불안제 약물로 사용가능한 산국화 추출물의 제조 방법(A method for preparing an extract of Crysanthemum indicum capable of being used as a small amount of anti-anxiety drug).
10-1702164-0000.
20170125.
KOREA, REPUBLIC OF
항우울 또는 항불안 활성을 갖는 3',4',7-트리하이드록시플라본 또는 이의 염을 포함하는 조성물.
10-2010-0009730.
20160325.
KOREA, REPUBLIC OF
두충피 추출물 또는 클로로제닉산을 유효성분으로 포함하는 파킨슨 질환의 예방 또는 치료용 약학 조성물.
10-2013-0022329.
20141126.
KOREA, REPUBLIC OF
백단향 추출물 또는 이의 분획물을 유효성분으로 포함하는 치매, 학습 장애 또는 기억력 손상 예방 또는 치료용 조성물.
10-2011-0049087.
20140728.
KOREA, REPUBLIC OF
학습 장애, 기억력 장애 또는 치매의 예방 또는 치료용 두충 추출물.
10-2008-0102789.
20140710.
KOREA, REPUBLIC OF
설퍼레틴 및 약학적으로 허용되는 이의 염을 포함하는 신경계 질환의 예방 및 치료용 약학 조성물.
10-2010-0027560.
20120612.
KOREA, REPUBLIC OF
Conference Paper
(2021)
Role of CYFIP2 on medial prefrontal cortex to nucleus accumbens pathway in regulation of cocaine reward.
2021 한국응용약물학회 학술대회.
KOREA, REPUBLIC OF
(2020)
7,3’,4’-Trihydroxyisoflavone ameliorates LPS-induced
neuroinflammation by regulating MAPKs and NF-κB
pathway in BV-2 microglial cells.
23회 뇌신경과학회.
KOREA, REPUBLIC OF
(2020)
Effect of transient receptor potential ankyrin type 1
receptor on ethanol addiction in mice.
23회 뇌신경과학회.
KOREA, REPUBLIC OF
(2020)
Role of CYFIP2 on medial prefrontal cortex to nucleus accumbens pathway in regulation of cocaine reward.
23회 뇌신경과학회.
KOREA, REPUBLIC OF
(2020)
The new psychoactive substance 4-methylmethylphenidate
exhibits rewarding properties and is mediated by dopamine
D1 receptor signaling.
23회 뇌신경과학회.
KOREA, REPUBLIC OF
(2020)
2C-C and 2C-P, new designer phenethylamines, have abuse properties and induce neurotoxicity in rodents.
대한약학회 2020.
KOREA, REPUBLIC OF
(2020)
Metoxphenidinge(MXP) caused several abnormalities: addictive behaviors and schizophrenia-related behaviors based on maladaptation of neurochemicals in the brain.
대한약학회 2020.
KOREA, REPUBLIC OF
(2020)
4-Methylmethylphenidate, the new psychoactive substance, exhibits addictive properites via dopaminergic system in mice.
응용약물학회 추계학술대회.
KOREA, REPUBLIC OF
(2020)
7,3’,4’-Trihydroxyisoflavone suppresses neuroinflammation via regulating MAPKs and NF-Kb pathways in LPS-stimulated BV-2 microglial cells.
응용약물학회 추계학술대회.
KOREA, REPUBLIC OF
(2020)
TRPA1 as a target for addictive disorders.
2020 Korean Society for molecular and Cellular Biology.
KOREA, REPUBLIC OF
(2019)
Korean Red Ginseng extract inhibits methamphetamine-induced addictive behaviors in rodents.
2019 Autumn Ginseng Jeju Conference.
KOREA, REPUBLIC OF
(2019)
6,7,4'-Trihydroxyisoflavone, a major metabolite of daidzein, inhibits 6-hydroxydopamine-induced oxidative stress and apoptosis in human neuroblastoma SH-SY5Y cells.
The 27th Annual Meeting & International Symposium of KSAP.
KOREA, REPUBLIC OF
(2019)
7,3’,4’-Trihydroxyisoflavone improves hippocampal cognitive function by regulating neurotrophic factors and BDNF signaling pathway in mice.
IBRO.
KOREA, REPUBLIC OF
(2019)
A new psychoactive substance, 25C-NBF, exhibits abuse potential and induce motor and memory impairments in rodents.
IBRO.
KOREA, REPUBLIC OF
(2019)
Inhibitory effects of Korean Red Ginseng Extract on methamphetamine-induced addictive behaviors in rodents.
IBRO.
KOREA, REPUBLIC OF
(2019)
Korean Red Ginseng extract mitigates CSDS-induced mood disorders by modulating NMDA receptor.
IBRO.
KOREA, REPUBLIC OF
(2019)
7,8,4'-Trihydroxyisoflavone Ameliorates Lipopolysaccharide-induced Anxiety-like Symptoms by Inhibition of Neuroinflammation and Modulation of p-CREB/BDNF Signaling in Mice.
2019 spring International Convention of the Pharmaceutical Society of Korea.
KOREA, REPUBLIC OF
(2019)
7,8,4'-Trihydroxyisoflavone Enhances Hippocampal Memory Function by Restoring Cholinergic System and BDNF Signaling Pathway in Mice.
2019 spring International Convention of the Pharmaceutical Society of Korea.
KOREA, REPUBLIC OF
(2019)
Mutation of CYFIP2 Attenuates Sensitivity to Cocaine Reward in Mice.
2019 spring International Convention of the Pharmaceutical Society of Korea.
KOREA, REPUBLIC OF
(2019)
Revision of accreditation standard area: Supporting students, faculties' education and research activities.
2019 spring International Convention of the Pharmaceutical Society of Korea.
KOREA, REPUBLIC OF